Duration of therapy | Standard care lifetime | Infliximab 1 year(2 year) | Adalimumab 1 year(2 year) |
Lifetime costs £K | 43.33 | 50.33 (58.23) | 46.73 (53.09) |
Lifetime effectiveness QALYs | 14.21 | 14.57 (14.90) | 14.68 (15.16) |
ICER £K per QALY | N/A | 19.05 (21.3) | 7.19 (10.31) |